Skol needs supervision while they trial his new meds. No contact with outside world until professionals can identify how to best cure the catalyst of his problems. Meanwhile....GO GOLD!!! GLTA
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market